Contactless Human-Machine-Interface Based on Magnetometers for Consumer Applications

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07466264

Enrollment

Registered

2026-03-12

Start date

2024-06-21

Completion date

2026-05-01

Last updated

2026-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adult

Brief summary

This study explores the use of novel, highly sensitive quantum-based magnetometers for creating a contactless human-machine interface for consumer applications. These sensors can detect extremely weak biomagnetic fields, such as those from the brain's neural activity (magnetoencephalography), at room temperature. The research aims to quantify interfering biological signals and evaluate the system's performance in detecting user intention for a simple use case. The results will serve as a foundation for developing future applications.

Interventions

DEVICEMagnetoencephalography using quantum-based magnetometers

Detection of extremely weak biomagnetic fields from the brain's neural activity (magnetoencephalography), to quantify interfering biological signals and evaluate the system's performance in detecting user intention for a simple use case.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

BASIC_SCIENCE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Are at least 18 years of age. * Are right-handed with normal or corrected vision. * Are employees of Robert Bosch GmbH and are participating in this study during their working hours. * They have no acute physical or psychological impairments. They are self-sufficient and have the legal capacity to consent. * They have provided written consent to participate in the study and for their data to be processed, and have not withdrawn this consent.

Exclusion criteria

* Pregnancy * Known cardiological, neurological, or psychiatric pre-existing conditions, especially epilepsy, claustrophobia, agoraphobia. * Metal-containing prostheses or pacemakers. * Inability to lie still for several minutes. * Body weight of more than 99 kg.

Design outcomes

Primary

Measure	Time frame
Amplitudes of acquired MEG signals	1 hour

Secondary

Measure	Time frame
Ratio of MEG signal to ambient noise level	1 hour
Modulation of magnetic power spectral density	1 hour

Countries

Germany

Contacts

PRINCIPAL_INVESTIGATOREckhard Wehrse, MD

Robert Bosch GmbH

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 23, 2026